Vir Biotechnology, Inc. VIR
- VIR-5500 — Metastatic Castration-Resistant Prostate Cancer Phase 1
- VIR-5500 — Metastatic Hormone-Sensitive Prostate Cancer Phase 1
PSMA (2 companies · 3 programs)
Companies with an active program directed at PSMA.
Janux Therapeutics, Inc. JANX
- JANX007 — Metastatic Castration-Resistant Prostate Cancer Phase 1